Vibrant Therapeutics is a clinical stage company that develops potential BIC and FIC  Masked T Cell Engager (mTCE) prodrugs for Oncology and Autoimmune disease & Inflammation using its LogicBee prodrug platform. As well as antibody-based drugs for neurology using its differentiated proprietary BBB-shuttle technology. We are looking for out-licensing, co-developing and partnering opportunities for our assets and technologies. We are open to explore funding opportunities as well.